Principal Financial Group Inc. Makes New $1.47 Million Investment in Surgery Partners, Inc. (NASDAQ:SGRY)

Principal Financial Group Inc. purchased a new stake in Surgery Partners, Inc. (NASDAQ:SGRYFree Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 45,552 shares of the company’s stock, valued at approximately $1,469,000.

Other large investors have also recently modified their holdings of the company. Bank of New York Mellon Corp raised its stake in Surgery Partners by 12.4% in the second quarter. Bank of New York Mellon Corp now owns 347,485 shares of the company’s stock valued at $8,267,000 after purchasing an additional 38,285 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in Surgery Partners by 21.1% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 15,504 shares of the company’s stock worth $369,000 after buying an additional 2,703 shares in the last quarter. Natixis Advisors LLC increased its holdings in shares of Surgery Partners by 11.0% in the 2nd quarter. Natixis Advisors LLC now owns 12,452 shares of the company’s stock worth $296,000 after buying an additional 1,237 shares during the last quarter. Rhumbline Advisers raised its position in shares of Surgery Partners by 19.6% during the 2nd quarter. Rhumbline Advisers now owns 127,952 shares of the company’s stock valued at $3,044,000 after buying an additional 20,963 shares in the last quarter. Finally, Arizona State Retirement System lifted its holdings in shares of Surgery Partners by 1.9% during the 2nd quarter. Arizona State Retirement System now owns 19,494 shares of the company’s stock worth $464,000 after acquiring an additional 359 shares during the last quarter.

Surgery Partners Stock Performance

Surgery Partners stock opened at $21.08 on Friday. Surgery Partners, Inc. has a 1-year low of $19.50 and a 1-year high of $35.29. The firm has a market cap of $2.68 billion, a P/E ratio of -43.92, a P/E/G ratio of 17.40 and a beta of 2.58. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.99. The firm has a 50-day moving average of $23.85 and a 200-day moving average of $27.43.

Surgery Partners (NASDAQ:SGRYGet Free Report) last issued its quarterly earnings data on Tuesday, November 12th. The company reported $0.19 earnings per share for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.06). The business had revenue of $770.40 million during the quarter, compared to the consensus estimate of $768.99 million. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. Surgery Partners’s quarterly revenue was up 14.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.15 earnings per share. Sell-side analysts expect that Surgery Partners, Inc. will post 0.71 EPS for the current year.

Analyst Upgrades and Downgrades

SGRY has been the topic of a number of research analyst reports. JPMorgan Chase & Co. reduced their target price on Surgery Partners from $38.00 to $28.00 and set a “neutral” rating on the stock in a research note on Tuesday, December 3rd. UBS Group started coverage on Surgery Partners in a report on Monday, October 14th. They set a “buy” rating and a $38.00 price objective on the stock. Cantor Fitzgerald restated an “overweight” rating and issued a $43.00 target price on shares of Surgery Partners in a research report on Friday, October 4th. Macquarie reiterated an “outperform” rating and set a $34.00 price target on shares of Surgery Partners in a research report on Tuesday, November 19th. Finally, Royal Bank of Canada lowered their price objective on shares of Surgery Partners from $49.00 to $35.00 and set an “outperform” rating for the company in a report on Wednesday, November 20th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat, Surgery Partners has a consensus rating of “Moderate Buy” and an average price target of $36.56.

Read Our Latest Stock Report on SGRY

Surgery Partners Profile

(Free Report)

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.

Recommended Stories

Institutional Ownership by Quarter for Surgery Partners (NASDAQ:SGRY)

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.